ABIONYX Pharma Market Cap

ABIONYX Pharma has a market cap or net worth of €118.36 million as of February 20, 2026. Its market cap has increased by 174.37% in one year.

Market Cap

118.36M

Enterprise Value

119.10M

Revenue

4.33M

Ranking

n/a

PE Ratio

n/a

Stock Price

€3.36

Market Cap Chart

Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 118.36M, a decrease of -44.73%. That is a compound annual growth rate of -5.29%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2026	118.36M	-11.36%
Dec 31, 2025	133.53M	223.58%
Dec 31, 2024	41.27M	-0.54%
Dec 29, 2023	41.49M	-14.37%
Dec 30, 2022	48.45M	-28.38%
Dec 31, 2021	67.65M	178.53%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cellectis	248.80M
Transgene	225.09M
MaaT Pharma	138.87M
Adocia	137.15M
Innate Pharma	131.78M
OSE Immunotherapeutics	96.41M
Sensorion	94.91M
Valerio Therapeutics Société anonyme	72.11M

Market Cap Rankings